| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 8.03e-10 | 37 | 56 | 6 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 9.51e-10 | 38 | 56 | 6 | GO:0070001 | |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 3.39e-06 | 11 | 56 | 3 | GO:0004523 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 7.44e-06 | 14 | 56 | 3 | GO:0003964 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 2.68e-05 | 21 | 56 | 3 | GO:0035613 | |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 1.41e-04 | 178 | 56 | 5 | GO:0015399 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 1.52e-04 | 37 | 56 | 3 | GO:0016891 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 1.64e-04 | 38 | 56 | 3 | GO:0034061 | |
| GeneOntologyMolecularFunction | endopeptidase activity | 1.91e-04 | 430 | 56 | 7 | GO:0004175 | |
| GeneOntologyMolecularFunction | phosphatidylcholine floppase activity | 2.14e-04 | 8 | 56 | 2 | GO:0090554 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 2.91e-04 | 46 | 56 | 3 | GO:0016893 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 3.51e-04 | 49 | 56 | 3 | GO:0140359 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor | 6.38e-04 | 60 | 56 | 3 | GO:0016655 | |
| GeneOntologyMolecularFunction | zinc ion binding | 7.73e-04 | 891 | 56 | 9 | GO:0008270 | |
| GeneOntologyMolecularFunction | floppase activity | 9.04e-04 | 16 | 56 | 2 | GO:0140328 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 1.42e-03 | 79 | 56 | 3 | GO:0004521 | |
| GeneOntologyMolecularFunction | phosphatidylcholine transporter activity | 1.42e-03 | 20 | 56 | 2 | GO:0008525 | |
| GeneOntologyMolecularFunction | peptidase activity | 2.25e-03 | 654 | 56 | 7 | GO:0008233 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on NAD(P)H | 2.41e-03 | 95 | 56 | 3 | GO:0016651 | |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 2.79e-03 | 28 | 56 | 2 | GO:0140326 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 3.55e-03 | 109 | 56 | 3 | GO:0042626 | |
| GeneOntologyMolecularFunction | oxidoreductase activity | 5.38e-03 | 766 | 56 | 7 | GO:0016491 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 5.45e-03 | 127 | 56 | 3 | GO:0016616 | |
| GeneOntologyMolecularFunction | transition metal ion binding | 5.50e-03 | 1189 | 56 | 9 | GO:0046914 | |
| GeneOntologyMolecularFunction | NADH dehydrogenase (ubiquinone) activity | 5.91e-03 | 41 | 56 | 2 | GO:0008137 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 6.23e-03 | 262 | 56 | 4 | GO:0140097 | |
| GeneOntologyMolecularFunction | RNA nuclease activity | 6.58e-03 | 136 | 56 | 3 | GO:0004540 | |
| GeneOntologyMolecularFunction | endonuclease activity | 6.58e-03 | 136 | 56 | 3 | GO:0004519 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH-OH group of donors | 6.85e-03 | 138 | 56 | 3 | GO:0016614 | |
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | 8.93e-03 | 152 | 56 | 3 | GO:0016779 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 9.02e-03 | 51 | 56 | 2 | GO:0140303 | |
| GeneOntologyMolecularFunction | SH2 domain binding | 9.36e-03 | 52 | 56 | 2 | GO:0042169 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 1.07e-02 | 477 | 56 | 5 | GO:0022804 | |
| GeneOntologyBiologicalProcess | DNA integration | 5.32e-06 | 13 | 56 | 3 | GO:0015074 | |
| GeneOntologyBiologicalProcess | RNA-templated DNA biosynthetic process | 7.63e-05 | 83 | 56 | 4 | GO:0006278 | |
| GeneOntologyBiologicalProcess | cell-cell fusion | 8.38e-05 | 85 | 56 | 4 | GO:0140253 | |
| GeneOntologyBiologicalProcess | syncytium formation by plasma membrane fusion | 8.38e-05 | 85 | 56 | 4 | GO:0000768 | |
| GeneOntologyBiologicalProcess | syncytium formation | 1.00e-04 | 89 | 56 | 4 | GO:0006949 | |
| Domain | PP-bd_ACP | 1.00e-04 | 6 | 49 | 2 | IPR009081 | |
| Domain | ABC_transporter_CS | 1.81e-04 | 42 | 49 | 3 | IPR017871 | |
| Domain | ABC_tran | 2.70e-04 | 48 | 49 | 3 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 2.70e-04 | 48 | 49 | 3 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 2.87e-04 | 49 | 49 | 3 | PS00211 | |
| Domain | ABC_transporter-like | 3.05e-04 | 50 | 49 | 3 | IPR003439 | |
| Domain | AAA+_ATPase | 5.49e-04 | 144 | 49 | 4 | IPR003593 | |
| Domain | AAA | 5.49e-04 | 144 | 49 | 4 | SM00382 | |
| Domain | ABC_membrane | 1.79e-03 | 24 | 49 | 2 | PF00664 | |
| Domain | GroES-like | 1.79e-03 | 24 | 49 | 2 | IPR011032 | |
| Domain | ABC_TM1F | 2.44e-03 | 28 | 49 | 2 | PS50929 | |
| Domain | ABC1_TM_dom | 2.44e-03 | 28 | 49 | 2 | IPR011527 | |
| Pathway | KEGG_ABC_TRANSPORTERS | 2.05e-04 | 44 | 37 | 3 | M11911 | |
| Pathway | REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_LIPOGENESIS | 2.39e-04 | 9 | 37 | 2 | M29789 | |
| Pathway | WP_LIVER_X_RECEPTOR_PATHWAY | 2.98e-04 | 10 | 37 | 2 | M39557 | |
| Pubmed | 2.95e-09 | 12 | 56 | 4 | 14557543 | ||
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 9.65e-09 | 94 | 56 | 6 | 21542922 | |
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 1.58e-08 | 4 | 56 | 3 | 10469592 | |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 3.94e-08 | 5 | 56 | 3 | 12629516 | |
| Pubmed | 7.88e-08 | 6 | 56 | 3 | 15063128 | ||
| Pubmed | 1.03e-06 | 331 | 56 | 7 | 29199018 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 12213084 | ||
| Pubmed | SREBP1/FASN/cholesterol axis facilitates radioresistance in colorectal cancer. | 2.55e-06 | 2 | 56 | 2 | 33665967 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 18420801 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 12897158 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 18281474 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 22786746 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 9060628 | ||
| Pubmed | Evolutionary relationships within a subgroup of HERV-K-related human endogenous retroviruses. | 2.55e-06 | 2 | 56 | 2 | 9460924 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 24105476 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 26134042 | ||
| Pubmed | Genetic variation in genes of the fatty acid synthesis pathway and breast cancer risk. | 7.63e-06 | 3 | 56 | 2 | 19252981 | |
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 38143182 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 33542341 | ||
| Pubmed | B7-H3 regulates lipid metabolism of lung cancer through SREBP1-mediated expression of FASN. | 7.63e-06 | 3 | 56 | 2 | 27939887 | |
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 12531699 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 28027934 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 10516026 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 33649289 | ||
| Pubmed | The role of CA-125, GLS and FASN in predicting cytoreduction for epithelial ovarian cancers. | 7.63e-06 | 3 | 56 | 2 | 32698888 | |
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 18682402 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 9971820 | ||
| Pubmed | Clinical importance of FASN in relation to HIF-1α and SREBP-1c in gastric adenocarcinoma. | 7.63e-06 | 3 | 56 | 2 | 30914315 | |
| Pubmed | LRF maintains genome integrity by regulating the non-homologous end joining pathway of DNA repair. | 8.28e-06 | 79 | 56 | 4 | 26446488 | |
| Pubmed | Role of the E3 ubiquitin-ligase Hakai in intestinal inflammation and cancer bowel disease. | 1.13e-05 | 27 | 56 | 3 | 36266428 | |
| Pubmed | HCBP6 Modulates Triglyceride Homeostasis in Hepatocytes Via the SREBP1c/FASN Pathway. | 1.52e-05 | 4 | 56 | 2 | 25855506 | |
| Pubmed | 1.52e-05 | 4 | 56 | 2 | 22331133 | ||
| Pubmed | 1.52e-05 | 4 | 56 | 2 | 23184344 | ||
| Pubmed | 1.52e-05 | 4 | 56 | 2 | 7983737 | ||
| Pubmed | 1.52e-05 | 4 | 56 | 2 | 20067991 | ||
| Pubmed | 1.52e-05 | 4 | 56 | 2 | 9890958 | ||
| Pubmed | Sp1 coordinately regulates de novo lipogenesis and proliferation in cancer cells. | 1.52e-05 | 4 | 56 | 2 | 19621387 | |
| Pubmed | 1.52e-05 | 4 | 56 | 2 | 23727646 | ||
| Pubmed | FASN KHDRBS1 ZBED4 MAGED2 GLS NOL6 UTP14A HADHA EPX ARID1A ABCB4 | 1.60e-05 | 1442 | 56 | 11 | 35575683 | |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | 1.81e-05 | 714 | 56 | 8 | 28302793 | |
| Pubmed | Mitochondrial protein interactome elucidated by chemical cross-linking mass spectrometry. | 1.89e-05 | 343 | 56 | 6 | 28130547 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | 1.98e-05 | 1203 | 56 | 10 | 29180619 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | MRPL50 KHDRBS1 MAGED2 TELO2 GLS UTP14A SCYL1 HADHA HERC1 NDUFA9 NDUFB5 | 2.25e-05 | 1496 | 56 | 11 | 32877691 |
| Pubmed | Transcriptionally active HERV-K genes: identification, isolation, and chromosomal mapping. | 2.54e-05 | 5 | 56 | 2 | 11401426 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | 2.68e-05 | 989 | 56 | 9 | 36424410 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | 2.88e-05 | 1257 | 56 | 10 | 36526897 | |
| Pubmed | 3.45e-05 | 382 | 56 | 6 | 29222160 | ||
| Pubmed | KLF15 Enables Rapid Switching between Lipogenesis and Gluconeogenesis during Fasting. | 3.80e-05 | 6 | 56 | 2 | 27545894 | |
| Pubmed | Identifying strategies to target the metabolic flexibility of tumours. | 3.80e-05 | 6 | 56 | 2 | 32694609 | |
| Pubmed | FGF11 induced by hypoxia interacts with HIF-1α and enhances its stability. | 5.54e-05 | 128 | 56 | 4 | 28027390 | |
| Pubmed | In vivo role of the HNF4alpha AF-1 activation domain revealed by exon swapping. | 6.10e-05 | 47 | 56 | 3 | 16498401 | |
| Pubmed | 8.05e-05 | 274 | 56 | 5 | 34244482 | ||
| Pubmed | FASN KHDRBS1 SYN2 MICAL3 LRRC7 HADHA NDUFA9 ARID1A NDUFB5 GOT1 | 8.53e-05 | 1431 | 56 | 10 | 37142655 | |
| Pubmed | 9.10e-05 | 9 | 56 | 2 | 23637738 | ||
| Pubmed | 1.14e-04 | 10 | 56 | 2 | 12970426 | ||
| Pubmed | 1.33e-04 | 61 | 56 | 3 | 20305087 | ||
| Pubmed | 1.66e-04 | 12 | 56 | 2 | 27307439 | ||
| Pubmed | 1.76e-04 | 67 | 56 | 3 | 16806233 | ||
| Pubmed | 1.96e-04 | 13 | 56 | 2 | 9107685 | ||
| Pubmed | Identification and Characterization of USP7 Targets in Cancer Cells. | 1.96e-04 | 13 | 56 | 2 | 30367141 | |
| Pubmed | 2.29e-04 | 14 | 56 | 2 | 25249504 | ||
| Pubmed | Polymorphisms in mitochondrial genes and prostate cancer risk. | 2.36e-04 | 74 | 56 | 3 | 19064571 | |
| Pubmed | 2.69e-04 | 193 | 56 | 4 | 19343046 | ||
| Pubmed | 2.78e-04 | 560 | 56 | 6 | 35241646 | ||
| Pubmed | 2.86e-04 | 360 | 56 | 5 | 33111431 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | 2.89e-04 | 1353 | 56 | 9 | 29467282 | |
| Pubmed | 2.96e-04 | 803 | 56 | 7 | 36517590 | ||
| Pubmed | 3.01e-04 | 16 | 56 | 2 | 8833906 | ||
| Pubmed | 3.41e-04 | 17 | 56 | 2 | 10982846 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 3.72e-04 | 1105 | 56 | 8 | 35748872 | |
| Pubmed | 3.83e-04 | 18 | 56 | 2 | 18664271 | ||
| Pubmed | 4.06e-04 | 215 | 56 | 4 | 30462309 | ||
| Pubmed | 4.21e-04 | 90 | 56 | 3 | 30459231 | ||
| Pubmed | 4.28e-04 | 19 | 56 | 2 | 26685326 | ||
| Pubmed | FBF1 deficiency promotes beiging and healthy expansion of white adipose tissue. | 4.28e-04 | 19 | 56 | 2 | 34348145 | |
| Pubmed | 4.32e-04 | 1429 | 56 | 9 | 35140242 | ||
| Pubmed | 4.43e-04 | 859 | 56 | 7 | 31536960 | ||
| Pubmed | 4.56e-04 | 1440 | 56 | 9 | 30833792 | ||
| Pubmed | 4.75e-04 | 20 | 56 | 2 | 22872236 | ||
| Pubmed | 4.75e-04 | 20 | 56 | 2 | 29385670 | ||
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | 4.82e-04 | 1451 | 56 | 9 | 30550785 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | 4.92e-04 | 1455 | 56 | 9 | 22863883 | |
| Pubmed | Expanding the Interactome of TES by Exploiting TES Modules with Different Subcellular Localizations. | 5.67e-04 | 235 | 56 | 4 | 28378594 | |
| Pubmed | 5.75e-04 | 1487 | 56 | 9 | 33957083 | ||
| Pubmed | 5.76e-04 | 22 | 56 | 2 | 20965718 | ||
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | 5.78e-04 | 420 | 56 | 5 | 28065597 | |
| Pubmed | 6.12e-04 | 650 | 56 | 6 | 38777146 | ||
| Pubmed | Identification of 18 mouse ABC genes and characterization of the ABC superfamily in Mus musculus. | 6.30e-04 | 23 | 56 | 2 | 10708515 | |
| Pubmed | 6.30e-04 | 23 | 56 | 2 | 26508642 | ||
| Pubmed | 6.30e-04 | 23 | 56 | 2 | 27974211 | ||
| Pubmed | 6.30e-04 | 23 | 56 | 2 | 14522948 | ||
| Pubmed | 6.30e-04 | 23 | 56 | 2 | 14662765 | ||
| Pubmed | CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI. | 6.42e-04 | 104 | 56 | 3 | 31240132 | |
| Pubmed | 6.47e-04 | 657 | 56 | 6 | 36180527 | ||
| Pubmed | 6.87e-04 | 24 | 56 | 2 | 37543677 | ||
| Pubmed | Genetic variants in nuclear-encoded mitochondrial genes influence AIDS progression. | 6.91e-04 | 926 | 56 | 7 | 20877624 | |
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | 7.16e-04 | 670 | 56 | 6 | 22990118 | |
| Pubmed | CLUH regulates mitochondrial metabolism by controlling translation and decay of target mRNAs. | 7.46e-04 | 25 | 56 | 2 | 28188211 | |
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | 7.62e-04 | 678 | 56 | 6 | 30209976 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | 7.64e-04 | 942 | 56 | 7 | 31073040 | |
| Interaction | ZBTB7A interactions | 1.07e-06 | 131 | 52 | 6 | int:ZBTB7A | |
| Interaction | ATP5MF interactions | 6.14e-06 | 177 | 52 | 6 | int:ATP5MF | |
| Interaction | MYL12A interactions | 9.78e-06 | 192 | 52 | 6 | int:MYL12A | |
| Cytoband | 15q22 | 5.60e-04 | 29 | 55 | 2 | 15q22 | |
| GeneFamily | ATP binding cassette subfamily B | 1.65e-04 | 11 | 32 | 2 | 806 | |
| GeneFamily | Short chain dehydrogenase/reductase superfamily | 3.24e-04 | 76 | 32 | 3 | 743 | |
| GeneFamily | NADH:ubiquinone oxidoreductase supernumerary subunits | 1.28e-03 | 30 | 32 | 2 | 1150 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.83e-06 | 198 | 50 | 5 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| Drug | 2,4,5-Trichlorophenoxyacetic Acid | 1.42e-07 | 107 | 51 | 6 | ctd:D015085 | |
| Drug | AC1L1B78 | 5.76e-07 | 72 | 51 | 5 | CID000001313 | |
| Drug | N-piperidinyl-(8-chloro-1-(2,4-dichlorophenyl)-1,4,5,6-tetrahydrobenzo(6,7)cyclohepta(1,2-c)pyrazole-3-carboxamide) | 1.47e-05 | 3 | 51 | 2 | ctd:C475771 | |
| Disease | aspartate aminotransferase to alanine aminotransferase ratio | 4.31e-05 | 239 | 48 | 5 | EFO_0010934 | |
| Disease | non-alcoholic fatty liver disease (biomarker_via_orthology) | 1.64e-04 | 65 | 48 | 3 | DOID:0080208 (biomarker_via_orthology) | |
| Disease | eotaxin measurement | 3.04e-04 | 80 | 48 | 3 | EFO_0008122 | |
| Disease | transforming growth factor beta measurement | 8.86e-04 | 27 | 48 | 2 | EFO_0004818 | |
| Disease | Malignant Neoplasms | 1.20e-03 | 128 | 48 | 3 | C0006826 | |
| Disease | Acute Coronary Syndrome | 1.32e-03 | 33 | 48 | 2 | C0948089 | |
| Disease | Liver carcinoma | 1.37e-03 | 507 | 48 | 5 | C2239176 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LRRDSDHRERAMMTM | 661 | O71037 | |
| LRRDSDHRERAMMTM | 661 | Q902F8 | |
| RRDSDHRERAMMTMA | 661 | Q9UKH3 | |
| TLLRLARMAEEMREA | 786 | Q96P50 | |
| RLRDTMRAMGLSRAV | 576 | Q8IZY2 | |
| EMIRDEGSSARSRML | 116 | Q76M96 | |
| METLMRSLDARLRAA | 96 | O95897 | |
| TVMSARDRYLARQMA | 531 | Q9H0G5 | |
| VSALRRFALSAMDME | 566 | O94925 | |
| TSVDMMRRAARALLA | 2226 | O14497 | |
| SVRMASSRMTRRDPL | 16 | Q6PKH6 | |
| SMMDRMFALERLART | 241 | Q96CN7 | |
| SQALRDAMARQLSRM | 1606 | Q7RTP6 | |
| SKALMASMARRASRG | 206 | Q9UNF1 | |
| RMDRIMESHLRAAEI | 516 | Q16706 | |
| TLAQMAMRSALARVV | 111 | Q6UYE1 | |
| ADSLVSATEMAMFRR | 1116 | Q96NW7 | |
| ARRLDMRSLECASMD | 1376 | O60303 | |
| ARTMVMRALSLLSVS | 3186 | Q15751 | |
| NERLTSDRGRALMFM | 211 | P11678 | |
| ARLSMMLLDSRADDG | 441 | Q9H6R4 | |
| MIAQRRDAMAHRILS | 131 | O95447 | |
| MDTMRSLRFISAEAL | 1 | A6NHZ5 | |
| STRRATSLELPMAMR | 2551 | Q9UMN6 | |
| MAMAMSDSGASRLRR | 1 | Q8IYI6 | |
| MAAAAQSRVVRVLSM | 1 | Q16795 | |
| LRRDSDHRERAMMTM | 1421 | P63135 | |
| EILTRRLRSMAFKAM | 781 | P21439 | |
| SLMEMTEAALRLLSR | 306 | P09923 | |
| RRLPTARMIAFAMAL | 81 | Q9NYX4 | |
| RRDSDHRERAMMTMA | 551 | P61566 | |
| LRRDSDHRERAMMTM | 661 | Q69384 | |
| RRDSDHRERAMMTMA | 551 | P61567 | |
| TMADRILTMRSELRA | 326 | P17174 | |
| AALDMMLTGRSIRAD | 196 | P40939 | |
| MQRRDDPAARMSRSS | 1 | Q07666 | |
| LRRDSDHRERAMMTM | 661 | Q902F9 | |
| MGLSLMRLDRFRDSI | 506 | P49327 | |
| ERMAVDMRRALFSSL | 221 | Q9NUT2 | |
| MFLDRAQRAGSVRMR | 76 | Q5QGT7 | |
| MMNFLRRRLSDSSFI | 1 | Q92777 | |
| TNVCRDASLMAMRRR | 421 | Q9BW62 | |
| DASLMAMRRRINGLS | 426 | Q9BW62 | |
| MAARSVSGITRRVFM | 1 | Q8N5N7 | |
| KMFSSTDRAMRIRLL | 356 | Q96KG9 | |
| RSAMAAVLAMRDLCR | 741 | P29590 | |
| LRDSRDELLASMMAG | 376 | Q9Y4R8 | |
| MTEMEISRAAAERSL | 91 | Q9NX55 | |
| DRDRARLDSMVLLIM | 346 | Q96QB1 | |
| AMRRVFLHEATARLM | 1031 | P36956 | |
| LSANRGDMRRMRSCI | 181 | Q86X19 | |
| DSLMRARAAVRAMGT | 566 | P17040 | |
| AMLGVTTVRSRMRRA | 141 | Q6NTF9 | |
| TTVRSRMRRALVFGM | 146 | Q6NTF9 | |
| MVRVRAVVMARDDSS | 1 | Q2MJR0 | |
| MAAMSLLRRVSVTAV | 1 | O43674 | |
| SLRAMSLEEAKMRRA | 211 | Q9BVJ6 | |
| RPTLRRVRISADAMM | 141 | P19429 | |
| DSGILRMMSRRDVRA | 221 | Q5W0B7 | |
| MLRSLKEAMVSRLSA | 981 | O75132 |